Gene · 9188
Papers1,289
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,289
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-Wide CRISPR Screens Identify Genome Stability as Regulator of the Cellular Sensitivity to Environmentally Relevant Bisphenol A Exposure. | Biomolecules | 2026 | 42793135 | PubTator, text mining | PubMed |
| DDX21 Enhances Radiosensitivity in Head and Neck Squamous Cell Carcinoma by Suppressing MK2-Mediated DNA Damage Response. | Adv Sci (Weinh) | 2026 | 42750169 | PubTator, text mining | PubMed |
| An ATP-Driven N Protein-DDX21 Molecular Switch Dynamically Controls SARS-CoV-2 RNA G-Quadruplex Heterogeneity. | Adv Sci (Weinh) | 2026 | 42750138 | PubTator, text mining | PubMed |
| KPNA1/importin α5 localizes to the nucleolus and associates with box C/D snoRNP complexes. | Biochem Biophys Res Commun | 2026 | 42659866 | PubTator, text mining | PubMed |
| Plakophilin 1 suppresses keratinocyte innate immune responses through DExD/H helicases. | Cell Mol Immunol | 2026 | 42618693 | PubTator, text mining | PubMed |
| R-loops in colorectal cancer: mechanisms, mapping strategies, and therapeutic opportunities. | Mol Biol Rep | 2026 | 42593691 | PubTator, text mining | PubMed |
| Histone Lactylation Mediated by circRNA-Facilitated FXR1 Phase Separation Promotes Colorectal Cancer Progression. | Cancer Res | 2026 | 42554628 | PubTator, text mining | PubMed |
| Human RPL7 and DDX21 function synergistically with HTLV-1 Gag to overcome genomic RNA structural barriers that block tRNAPro primer annealing. | Nucleic Acids Res | 2026 | 42444604 | PubTator, text mining | PubMed |
| The complete mitochondrial genome of the Boulenophrys xianjuensis (Anura: Megophryidae). | Mitochondrial DNA B Resour | 2026 | 42370214 | PubTator, text mining | PubMed |
| DDX21 Promotes Breast Cancer Growth and Metastasis via Stimulating RNAPII Elongation During Hypoxia. | MedComm (2020) | 2026 | 42311859 | PubTator, text mining | PubMed |
| The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1. | Oncogene | 2026 | 42098442 | PubTator, text mining | PubMed |
| Ubiquitination of DDX21 by HERC2 induces a dormancy-like phenotype via the NUCKS1-p21/p27 axis to promote radio-resistance in colorectal cancer cells. | Cell Death Dis | 2026 | 42071007 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens identify DNA repair and R-loop suppression as regulators of the cellular sensitivity to environmentally relevant Bisphenol A exposure. | bioRxiv | 2026 | 42039408 | PubTator, text mining | PubMed |
| DDR1 Promotes Immune Evasion in Colorectal Cancer by Orchestrating IL33-Mediated M2-like Polarization of Tumor-Associated Macrophages. | Cancer Immunol Res | 2026 | 41962054 | PubTator, text mining | PubMed |
| TRF2-RAP1 inhibits homology-directed repair of telomeres by promoting BLM-mediated removal of telomere R-loops. | Nucleic Acids Res | 2026 | 41914496 | PubTator, text mining | PubMed |
| Direct interaction between human DDX1 and SARS-CoV-2 nucleocapsid protein is regulated by phosphorylation. | J Biol Chem | 2026 | 41903808 | PubTator, text mining | PubMed |
| USP10 deubiquitinase: Physiological function, diseases and therapeutic target (Review). | Int J Mol Med | 2026 | 41891958 | PubTator, text mining | PubMed |
| Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic target. | Nat Commun | 2026 | 41872184 | PubTator, text mining | PubMed |
| DDX21 Links BRAFV600E and TERT to Promote Thyroid Cancer Progression. | Thyroid | 2026 | 41817108 | PubTator, text mining | PubMed |
| Assessing the contributions of noncoding RNAs in acute myeloid leukemia. | Blood Neoplasia | 2026 | 41798679 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9188/papers